16Feb 2025
Combination Therapy Enhances PCOS Management

Combination Therapy Enhances PCOS Management

A new network meta-analysis of 29 RCTs reveals that combining standard therapy with GLP-1 receptor agonists significantly improves metabolic outcomes in women with PCOS, reducing weight, BMI, and insulin resistance. Orlistat effectively lowers testosterone and boosts HDL-C levels. These findings highlight the benefits of combination pharmacotherapy for better PCOS management.

  • #gynaecology - ivf

Like

Save

Share